Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU Topics

ICU ·

Ogilvie syndrome (acute colonic pseudo-obstruction)

Also known as Acute colonic pseudo-obstruction (ACPO) · Ogilvie syndrome · Acute adynamic ileus of the colon · Colonic pseudo-obstruction · Non-mechanical colonic obstruction · Neostigmine-responsive colonic ileus · Caecal perforation risk (ACPO) · Percutaneous caecostomy · Ponec neostigmine trial · ASCRS ACPO guideline

Ogilvie syndrome (acute colonic pseudo-obstruction, ACPO) is massive colonic dilation WITHOUT mechanical obstruction, attributed to an imbalance in autonomic regulation of colonic motor function — excessive parasympathetic suppression or sympathetic stimulation — producing colonic atony, although the exact pathophysiology remains unclear. It is a disease of the hospitalised: precipitants include recent surgery (orthopaedic, cardiac, caesarean, abdominal), critical illness/sepsis, electrolyte disturbance, opioids and anticholinergics, immobility, retroperitoneal pathology, trauma, burns, and metabolic disease. Presentation is progressive, often painless, abdominal distension developing over several days with tympani, minimal or absent bowel sounds, and nausea; pain disproportionate to the picture or peritonism signals ischaemia or perforation. Diagnosis is clinical plus imaging: plain AXR (and confirmatory CT with contrast) showing caecal dilation, with explicit exclusion of mechanical obstruction. Perforation risk increases when caecal diameter exceeds 12 cm AND distension has been present for more than 6 days; mortality is approximately 40% once ischaemia or perforation occurs. Management is staged: conservative measures first (bowel rest, NG and rectal tubes, electrolyte correction, stopping causative drugs, mobilisation); if refractory, neostigmine 2-2.5 mg IV (2.0 mg in the pivotal randomised trial, 91% response vs 0% placebo) with continuous cardiac monitoring and atropine available; colonoscopic decompression for neostigmine failure or contraindication (pooled first-session success 78.8%, overall 91.5%); surgery for peritonitis, ischaemia or perforation.

low20 referencesUpdated 20 Aug 202617 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Caecal diameter >12 cm OR duration >6 days = high perforation risk — escalate beyond conservative therapy
  • Exclude mechanical obstruction with water-soluble contrast enema or CT BEFORE giving neostigmine — prokinetic against a mechanical blockage causes blow-out perforation
  • Neostigmine causes bradycardia, bronchospasm, hypotension, and AV block — continuous ECG, atropine drawn up at the bedside, bedpan ready (rapid decompression)
  • Correct electrolytes (K, Mg, Ca) — hypokalaemia and hypomagnesaemia worsen colonic atony and are reversible precipitants
  • New pain or peritonism in a dilated colon = ischaemia or perforation until proven otherwise — urgent surgical review
  • Pregnancy/postpartum and cardiac/orthopaedic post-op are classic settings — keep Ogilvie on the differential for unexplained distension
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Caecal diameter >12 cm OR duration >6 days = high perforation risk — escalate beyond conservative therapy
  • Exclude mechanical obstruction with water-soluble contrast enema or CT BEFORE giving neostigmine — prokinetic against a mechanical blockage causes blow-out perforation
  • Neostigmine causes bradycardia, bronchospasm, hypotension, and AV block — continuous ECG, atropine drawn up at the bedside, bedpan ready (rapid decompression)
  • Correct electrolytes (K, Mg, Ca) — hypokalaemia and hypomagnesaemia worsen colonic atony and are reversible precipitants
  • New pain or peritonism in a dilated colon = ischaemia or perforation until proven otherwise — urgent surgical review
  • Pregnancy/postpartum and cardiac/orthopaedic post-op are classic settings — keep Ogilvie on the differential for unexplained distension
The one-line answer

Ogilvie syndrome (acute colonic pseudo-obstruction, ACPO) is massive colonic dilation without mechanical obstruction, attributed to an imbalance in autonomic regulation of colonic motor function — excessive parasympathetic suppression or sympathetic stimulation — that leaves the colon atonic. The dilated caecum is the perforation risk. The ladder is staged and simple: exclude the block, correct the electrolytes, give neostigmine 2-2.5 mg IV when conservative care fails, colonoscopy if it fails, surgery last. Perforation risk increases when the caecum exceeds 12 cm or distension has lasted more than 6 days.[12][11][6]

Meet the patient

A 72-year-old man, day 5 after a left total hip replacement, is flagged by the nurses for a belly that has been silently ballooning for three days. He takes oxycodone, has not passed flatus, and — the detail to anchor on — is in no pain despite a girth past 100 cm. The AXR shows a caecum of 12.5 cm.[3][12]

Three questions decide the next hour, and every ACPO stem turns on them: is this Ogilvie or a mechanical block? is it toxic megacolon? and is that caecum about to rupture? Hold those three and the ladder below slots into place.[3]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References20ShowHide
  1. [1]Vogel JD, Feingold DL, Stewart DB, Turner JS, Boutros M, Chun J, Steele SR Clinical Practice Guidelines for Colon Volvulus and Acute Colonic Pseudo-Obstruction Dis Colon Rectum, 2016.PMID 27270510
  2. [2]Ponec RJ, Saunders MD, Kimmey MB Neostigmine for the treatment of acute colonic pseudo-obstruction N Engl J Med, 1999.PMID 10403850
  3. [3]Vanek VW, Al-Salti M Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases Dis Colon Rectum, 1986.PMID 3753674
  4. [4]Underhill J, Munding E, Hayden D Acute Colonic Pseudo-obstruction and Volvulus: Pathophysiology, Evaluation, and Treatment Clin Colon Rectal Surg, 2021.PMID 34305473
  5. [5]Arthur T, Burgess A Acute Colonic Pseudo-Obstruction Clin Colon Rectal Surg, 2022.PMID 35966377
  6. [6]Saunders MD Acute colonic pseudo-obstruction Gastrointest Endosc Clin N Am, 2007.PMID 17556152
  7. [7]Naveed M, Jamil LH, Fujii-Lau LL, et al American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus Gastrointest Endosc, 2020.PMID 31791596
  8. [8]Keller J, Layer P [Acute colonic pseudo-obstruction: Ogilvie syndrome]. Med Klin Intensivmed Notfmed, 2015.PMID 26400054
  9. [9]Jayaram P, Mohan M, Lindow S Postpartum Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome): A systematic review of case reports and case series Eur J Obstet Gynecol Reprod Biol, 2017.PMID 28531835
  10. [10]Bernardi MP, Warrier S, Lynch AC Acute and chronic pseudo-obstruction: a current update ANZ J Surg, 2015.PMID 25943300
  11. [11]De Giorgio R, Barbara G, Stanghellini V, et al Review article: the pharmacological treatment of acute colonic pseudo-obstruction Aliment Pharmacol Ther, 2001.PMID 11683685
  12. [12]Saunders MD, Kimmey MB Systematic review: acute colonic pseudo-obstruction Aliment Pharmacol Ther, 2005.PMID 16268965
  13. [13]Valle RG, Godoy FL Neostigmine for acute colonic pseudo-obstruction: A meta-analysis Ann Med Surg (Lond), 2014.PMID 25568788
  14. [14]Giri S, Krishnamurthy V, Shah D, et al Outcome of colonoscopic decompression in acute colonic pseudo-obstruction: A systematic review and meta-analysis World J Crit Care Med, 2025.PMID 40880578
  15. [15]Geller A, Petersen BT, Gostout CJ Endoscopic decompression for acute colonic pseudo-obstruction Gastrointest Endosc, 1996.PMID 8858319
  16. [16]Liu JJ, Venkatesh V, Gao J, et al Efficacy and Safety of Neostigmine and Decompressive Colonoscopy for Acute Colonic Pseudo-Obstruction: A Single-Center Analysis Gastroenterol Res, 2021.PMID 34267830
  17. [17]Kim TJ, Torres L, Paz A, et al Neostigmine for Treating Acute Colonic Pseudo-Obstruction in Neurocritically Ill Patients J Clin Neurol, 2021.PMID 34595865
  18. [18]Eaker EY Update on acute colonic pseudo-obstruction Curr Gastroenterol Rep, 2001.PMID 11560803
  19. [19]Gebre-Giorgis AA, Roderique EJ, Stewart D, et al Neostigmine to relieve a suspected colonic pseudo-obstruction in a burn patient: a case-based review of the literature Eplasty, 2013.PMID 23359843
  20. [20]Frankel A, Gillespie C, Lu CT, et al Subcutaneous neostigmine appears safe and effective for acute colonic pseudo-obstruction (Ogilvie's syndrome) ANZ J Surg, 2019.PMID 31083785

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeutropenic Sepsis — The Golden Hour & the Antipseudomonal Beta-LactamInfection / oncologyNextToxic megacolon and acute severe colitis